Skip to main content

Elmind Capital, LP

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 2052213 NEW YORK, NY

Position in BCRX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$5,200,000
-$4,320,000 QoQ
Shares Held
520,000
-48.0% QoQ
Ownership
0.203%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#61
of 316 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCRX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Elmind Capital, LP holds $18,594,670 across 4 Drug Manufacturers - Specialty & Generic names. BCRX ranks #2 (28.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 BCRX
Biocryst Pharmaceuticals Inc
This page
520,000 $5,200,000

All Filings in BCRX

Export CSV
3 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,200,000 520,000
2026-03-31 $9,520,000 1,000,000
2025-12-31 $16,770,000 2,150,000